Login
$ISBA
$39.69 +$0.33 (0.84%) Close

Interim condensed consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Cash and demand deposits due from banks
Federal funds sold and interest bearing balances due from banks
Total cash and cash equivalents
Marketable securities AFS (amortized cost of $450,111 and $507,689, respectively)
Mortgage loans HFS
Loans
Loans and Leases Receivable, Gross
Less allowance for loan losses
Net loans
Loans held for investment
Allowance for credit losses
Loans, net
FHLB stock, at cost
Premises and equipment
Cash surrender value of BOLI
Equity securities without readily determinable fair values
Goodwill and other intangible assets
Other assets
Total assets
LIABILITIES AND SHAREHOLDERS’ EQUITY
Liabilities
Noninterest bearing demand deposits
NOW accounts
Interest bearing deposits
Interest bearing demand deposits
Certificates of deposit under $250 and other savings
Certificates of deposit over $250
Money market deposits
Savings
Certificates of deposit
Total deposits
Short-term borrowings
FHLB advances
Subordinated debt, net of unamortized issuance costs
Total borrowed funds
Accrued interest payable and other liabilities
Other liabilities
Total liabilities
Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance
Common Stock, Shares, Outstanding
Shareholders’ equity
Common stock — no par value, 15,000,000 shares authorized: issued and outstanding 7,628,809 shares at June 30, 2026 and 7,322,207 shares at December 31, 2025
Shares to be issued for deferred compensation obligations
Retained earnings
Accumulated other comprehensive loss
Total shareholders’ equity
Total liabilities and shareholders’ equity
Common Stock, Shares Authorized

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support